MB
Mathew Blackman Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Inogen
INGN
$223M
| $8.26 | $7 |
15%
downside
| Hold |
8 May ‘25
4 months ago |
|
2
Tandem Diabetes Care
TNDM
$849M
| $12.57 | $31 |
147%
upside
| Buy |
1 May ‘25
4 months ago |
|
3
Penumbra
PEN
$10.8B
| $276.86 | $318 |
15%
upside
| Buy |
24 Apr ‘25
4 months ago |
|
4
ClearPoint Neuro
CLPT
$304M
| $10.70 | $25 |
134%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
|
BBNX
5
Beta Bionics, Inc. Common Stock
BBNX
$1.09B
| $25 | $25 |
0%
upside
| Buy |
24 Feb ‘25
6 months ago |
|
6
Insulet
PODD
$23.9B
| $340.16 | $293 |
14%
downside
| Hold |
21 Feb ‘25
6 months ago |
|
7
Globus Medical
GMED
$7.9B
| $58.51 | $94 |
61%
upside
| Buy |
21 Feb ‘25
6 months ago |
|
8
Orthofix Medical
OFIX
$566M
| $14.32 | $24 |
68%
upside
| Buy |
8 Nov ‘24
10 months ago |
|
9
Cerus
CERS
$234M
| $1.22 | $3 |
146%
upside
| Buy |
17 Oct ‘24
10 months ago |
|
10
DexCom
DXCM
$30B
| $76.38 | $100 |
31%
upside
| Buy |
23 Aug ‘24
1 year ago |
|
11
Alphatec Holdings
ATEC
$2.32B
| $15.70 | $16 |
2%
upside
| Buy |
1 Aug ‘24
1 year ago |
|
12
AdaptHealth
AHCO
$1.24B
| $9.14 | $11 |
20%
upside
| Hold |
10 May ‘23
2 years ago |
|